You will be redirected to:
Keyrus launches Keyrus Life Science, the first Connected-CRO (C2RO), designed to accelerate the Health industry’s digital transformation.
Levallois-Perret, 28 January 2020: An international player in the fields of Data Intelligence, Digital, and Consulting on the Management and Transformation of enterprises, the Keyrus Group announces the launch of Keyrus Life Science, the first Connected-CRO (C2RO) designed to facilitate and accelerate the digital transformation of enterprises in the Health sector in the Data-Digital era.
"The development of Keyrus Life Science (formerly known as Keyrus Biopharma) is based on the premise that it is only by giving meaning to data that mankind can solve the major health issues it must tackle as quickly as possible", declares Xavier Dehan, Associate General Manager and Business Director of Keyrus Life Science, France. "Keyrus Life Science is a unique Connected Clinical CRO that enhances the performance and speed of execution of clinical trials by valorizing extended data."
Keyrus Life Science helps connect industry expertise, Life Data Sciences and Digital Enablement to fully leverage both Clinical Research ecosystems and Real-World Evidence/RWE in healthcare, thus enhancing the reliability, innovative capacity, agility, and, above all, speed of execution of Clinical Research activities.
By capitalizing on digital technologies, data sciences and honed industry expertise, Keyrus Life Science creates a unique value proposition. Keyrus Life Science unlocks for its clients the means to achieve digitalization across all Life Science industry segments and throughout all phases of the R&D cycle, from the earliest clinical stages, through to Real World Evidence and insights in a post-marketing setting.
"Keyrus Life Science fits into the Keyrus Group’s vision and shares both its values, and its keen innovative spirit", declares Eric Cohen, CEO of Keyrus. "Drawing upon highly original ways of using and valorizing health data, Keyrus Life Science’s proposition is unique in the market today. Combined with the Keyrus Group’s longstanding Data-Digital expertise, Keyrus Life Science’s offering thus brings innovative and concrete solutions to companies in this sector to help them provide effective answers to the major health issues."
Benefiting from over 20 years’ experience, Keyrus Life Science’s services and offerings cover all aspects of Clinical Research, both current and future:
C2RO : Regulatory affairs, Clinical operations, Data management, Statistics, Medical writing
Life Data Sciences : Real-World Data analytics, Health data insights, Smart Study Planner®, Artificial Intelligence
Digital Enablement: Digital platforms, Wearables, Digital patient recruitment, e-Health solutions
By improving data collection and quality, patient recruitment and adherence, and by making sense of extended ecosystem data, Keyrus Life Science contributes to enhancing Clinical Research & Development practices to promote better healthcare!
Keyrus Life Science has more than 300 employees and operates in Europe, North America, and the MEA regions.
Stay updated on the latest articles, events, and more
Nowadays, all companies active in the life science ecosystem consider data as a crucial asset to their success. Pharma companies are collecting more and more information during their clinical trials or commercial and medical activities. Clinical laboratories have to deploy complex data infrastructures to better serve their patients and clients, and Biotech and MedTech companies need to gather and analyze a lot of scientific and technical data.
Paris 9th January, 2023 (France) - Today, EvidentIQ, a leading clinical data science group and Keyrus Life Science, the international Connected Contract Research Organization (C²RO), announced the signing of a strategic partnership. The synergy between both companies will improve automation, efficiency and agility in clinical research by leveraging new eClinical capabilities.
Paris, Levallois-Perret, November 7th, 2022 - Keyrus Life Science and Parean Biotechnologies will join their expertise in data science and technologies to meet the most critical challenges for clients in the fields of biometry, biostatistics and bioinformatics.
This summer was very busy and interesting for the Keyrus Life Science North America Team. We attended three pivotal life science conferences: Decentralized Clinical Trials Conference, BIO International Convention, and DIA Conference.
Paris, Levallois-Perret, June 23, 2022 - Keyrus Life Science announces the launch of its new visual identity strengthening its synergies with the Keyrus Group to address the most pressing challenges of its clients in the life science industry and to drive clinical research forward.
Digitalization, data and connectivity has become part of our daily lives in all its dimensions.
Clinical trials produce a massive amount of data. In most cases, the challenge lies less in the volume of data to process, but more in its diversity. The sources of data are indeed numerous and do not stop increasing.
The World Heart Day, an occasion to remind us all, that cardiovascular diseases (CVD) causes more than 18 million of deaths per year.
Today, September 21st, is the World Alzheimer’s Day, so let’s do a quick review of the investigated therapeutic targets to find a cure to this pathology
Keyrus Life Science joined the Keyrus Foundation in the team sports challenge 'Connected against hunger'